Abstract
In spite of the guidelines for an improvement, the follow up of vascular accesses remains insufficient, due to the costs and the burden for the patients. The rate of thrombosis of vascular access reaches 10% per annum. We assumed that the plasmatic level of osteopontin (OPN), a pro-inflammatory molecule correlated with intimal hyperplasia, could be a predictive marker of stenosis in hemodialysis patients with an arteriovenous fistula (AVF), which could allow the detection of the AVFs at risk of thrombosis by a biological test.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
